{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:45:44Z","timestamp":1753890344587,"version":"3.41.2"},"reference-count":38,"publisher":"XMLink","issue":"42","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Korean Med Sci"],"DOI":"10.3346\/jkms.2021.36.e298","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T05:55:26Z","timestamp":1635400526000},"source":"Crossref","is-referenced-by-count":6,"title":["Antivirals for Coexistence with COVID-19: Brief Review for General Physicians"],"prefix":"10.3346","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-3399","authenticated-orcid":false,"given":"Jin-Hong","family":"Yoo","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary's Hospital, Bucheon, Korea."},{"name":"Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18617","published-online":{"date-parts":[[2021]]},"reference":[{"issue":"4","key":"10.3346\/jkms.2021.36.e298_ref1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.3346\/jkms.2020.35.e56","volume":"35","author":"Yoo","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.3346\/jkms.2021.36.e298_ref2","unstructured":"Korea Disease Control and Prevention Agency. Regular briefing on October-20, 2021. Updated 2021. Accessed October 21, 2021. http:\/\/ncov.mohw.go.kr\/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6023&contSeq=6023&board_id=312&gubun=ALL"},{"key":"10.3346\/jkms.2021.36.e298_ref3","unstructured":"COVIDvax.live in South Korea. Updated 2021. Accessed Octobor 25, 2021. https:\/\/covidvax.live\/location\/kor"},{"key":"10.3346\/jkms.2021.36.e298_ref4","unstructured":"Yonhap News Agency. S. Korea to consider \u2018With Corona\u2019 in second week of Nov.: top health official. Updated 2021. Accessed October 10, 2021. https:\/\/en.yna.co.kr\/view\/AEN20211007008100320"},{"issue":"32","key":"10.3346\/jkms.2021.36.e298_ref5","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.3346\/jkms.2021.36.e231","volume":"36","author":"Jung","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.3346\/jkms.2021.36.e298_ref6","doi-asserted-by":"crossref","first-page":"e0010921","DOI":"10.1128\/CMR.00109-21","volume":"34","author":"Tao","year":"2021","journal-title":"Clin Microbiol Rev"},{"issue":"7854","key":"10.3346\/jkms.2021.36.e298_ref7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/d41586-021-00958-4","volume":"592","author":"Dolgin","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.3346\/jkms.2021.36.e298_ref8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.3346\/jkms.2021.36.e298_ref9","doi-asserted-by":"crossref","first-page":"e00483","DOI":"10.1128\/AAC.00483-20","volume":"64","author":"Li","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.3346\/jkms.2021.36.e298_ref10","doi-asserted-by":"crossref","first-page":"e1003565","DOI":"10.1371\/journal.ppat.1003565","volume":"9","author":"Smith","year":"2013","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.3346\/jkms.2021.36.e298_ref11","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1002\/jmv.27009","volume":"93","author":"Tahir","year":"2021","journal-title":"J Med Virol"},{"issue":"2","key":"10.3346\/jkms.2021.36.e298_ref12","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1073\/pnas.1718806115","volume":"115","author":"Ferron","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.3346\/jkms.2021.36.e298_ref13","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"issue":"7","key":"10.3346\/jkms.2021.36.e298_ref14","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.molcel.2021.01.035","volume":"81","author":"Bravo","year":"2021","journal-title":"Mol Cell"},{"issue":"1","key":"10.3346\/jkms.2021.36.e298_ref15","doi-asserted-by":"crossref","first-page":"100867","DOI":"10.1016\/j.jbc.2021.100867","volume":"297","author":"Men\u00e9ndez-Arias","year":"2021","journal-title":"J Biol Chem"},{"issue":"1","key":"10.3346\/jkms.2021.36.e298_ref16","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.jbc.2021.100770","volume":"297","author":"Gordon","year":"2021","journal-title":"J Biol Chem"},{"issue":"9","key":"10.3346\/jkms.2021.36.e298_ref17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"10.3346\/jkms.2021.36.e298_ref18","doi-asserted-by":"crossref","first-page":"e02479-20","DOI":"10.1128\/AAC.02479-20","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"journal-title":"J Med Chem","year":"2021","author":"Cannalire","key":"10.3346\/jkms.2021.36.e298_ref19"},{"key":"10.3346\/jkms.2021.36.e298_ref20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coviro.2021.04.006","volume":"49","author":"Vandyck","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.3346\/jkms.2021.36.e298_ref21","doi-asserted-by":"crossref","first-page":"671263","DOI":"10.3389\/fmolb.2021.671263","volume":"8","author":"Mei","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"8","key":"10.3346\/jkms.2021.36.e298_ref22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res"},{"key":"10.3346\/jkms.2021.36.e298_ref23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2021.09.023","volume":"578","author":"Ryu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.3346\/jkms.2021.36.e298_ref24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41564-021-00972-2","volume":"6","author":"Dong","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.3346\/jkms.2021.36.e298_ref25","unstructured":"AstraZeneca. COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials. Updated 2020. Accessed October 1, 2021. https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2020\/covid-19-long-acting-antibody-laab-combination-azd7442-rapidly-advances-into-phase-iii-clinical-trials.html"},{"issue":"6521","key":"10.3346\/jkms.2021.36.e298_ref26","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.abe0075","volume":"370","author":"Linsky","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.3346\/jkms.2021.36.e298_ref27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bcpt.13533","volume":"128","author":"Breining","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"10.3346\/jkms.2021.36.e298_ref28","doi-asserted-by":"crossref","first-page":"e00754","DOI":"10.1128\/AAC.00754-20","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3346\/jkms.2021.36.e298_ref29","unstructured":"Korea Clinical Trials Information Center. Summary of COVID-19 clinical trials as of 20211012. Updated 2021. Accessed October 10, 2021. https:\/\/www.koreaclinicaltrials.org\/kr\/board\/covid19_smry\/boardView.do?bbsIdx=1332&pageIndex=1&searchCondition=&searchKeyword="},{"issue":"6","key":"10.3346\/jkms.2021.36.e298_ref30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.3346\/jkms.2021.36.e298_ref31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12941-020-00368-w","volume":"19","author":"Sharun","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.3346\/jkms.2021.36.e298_ref32","unstructured":"World Health Organization. WHO's Solidarity clinical trial enters a new phase with three new candidate drugs. Updated 2021. Accessed October 10, 2021. https:\/\/www.who.int\/news\/item\/11-08-2021-who-s-solidarity-clinical-trial-enters-a-new-phase-with-three-new-candidate-drugs"},{"issue":"11","key":"10.3346\/jkms.2021.36.e298_ref33","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.3346\/jkms.2021.36.e83","volume":"36","author":"Joo","year":"2021","journal-title":"J Korean Med Sci"},{"journal-title":"medRxiv","year":"2021","author":"Fischer","key":"10.3346\/jkms.2021.36.e298_ref34"},{"key":"10.3346\/jkms.2021.36.e298_ref35","unstructured":"Korea Herald. S. Korea's hope for normalization boosted with positive trial results from Merck. Updated 2021. Accessed October 10, 2021. http:\/\/www.koreaherald.com\/view.php?ud=20211002000066"},{"issue":"28","key":"10.3346\/jkms.2021.36.e298_ref36","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1073\/pnas.1421733112","volume":"112","author":"Sohl","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.3346\/jkms.2021.36.e298_ref37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jiab247","volume":"224","author":"Zhou","year":"2021","journal-title":"J Infect Dis"},{"key":"10.3346\/jkms.2021.36.e298_ref38","unstructured":"Korea Herald. Controversy growing over price paid for COVID-19 treatments. Updated 2021. Accessed October 10, 2021. https:\/\/www.koreatimes.co.kr\/www\/nation\/2021\/09\/119_315334.html"}],"container-title":["Journal of Korean Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jkms.org\/pdf\/10.3346\/jkms.2021.36.e298","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2021.36.e298","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2021.36.e298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:27:30Z","timestamp":1673656050000},"score":1,"resource":{"primary":{"URL":"https:\/\/jkms.org\/DOIx.php?id=10.3346\/jkms.2021.36.e298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":38,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3346\/jkms.2021.36.e298","relation":{},"ISSN":["1011-8934","1598-6357"],"issn-type":[{"type":"print","value":"1011-8934"},{"type":"electronic","value":"1598-6357"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"e298"}}